An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies ; volume:80 ; number:1 ; day:10 ; month:12 ; year:2022 ; pages:1-20 ; date:1.2023
Cellular and molecular life sciences ; 80, Heft 1 (10.12.2022), 1-20, 1.2023
- Urheber
-
Orlando, Eleonora
Medo, Matúš
Bensimon, Ariel
Quintin, Aurélie
Riedo, Rahel
Roth, Selina M.
Riether, Carsten
Marti, Thomas M.
Aebersold, Daniel M.
Medová, Michaela
Aebersold, Ruedi
Zimmer, Yitzhak
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00018-022-04634-2
- URN
-
urn:nbn:de:101:1-2502271321255.673547070742
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Orlando, Eleonora
- Medo, Matúš
- Bensimon, Ariel
- Quintin, Aurélie
- Riedo, Rahel
- Roth, Selina M.
- Riether, Carsten
- Marti, Thomas M.
- Aebersold, Daniel M.
- Medová, Michaela
- Aebersold, Ruedi
- Zimmer, Yitzhak
- SpringerLink (Online service)
Ähnliche Objekte (12)
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
Oncogene addiction in gliomas: Implications for molecular targeted therapy
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction
Acquisition of chromosome instability is a mechanism to evade oncogene addiction
A CIN ful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
Oncogene : including Oncogene reviews
Non-oncogene addiction of mixed-lineage Leukemia to CCAAT enhancer-binding proteins (C/EBPs)
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
Oncogene addiction in gliomas: Implications for molecular targeted therapy
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction
Acquisition of chromosome instability is a mechanism to evade oncogene addiction
A CIN ful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
Oncogene : including Oncogene reviews
Non-oncogene addiction of mixed-lineage Leukemia to CCAAT enhancer-binding proteins (C/EBPs)
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
Oncogene addiction in gliomas: Implications for molecular targeted therapy
Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Interplay between HSF1 and p53 signaling pathways in cancer initiation and progression: non-oncogene and oncogene addiction
Acquisition of chromosome instability is a mechanism to evade oncogene addiction
A CIN ful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers
Drugging the addict: non‐oncogene addiction as a target for cancer therapy
Oncogene : including Oncogene reviews
Non-oncogene addiction of mixed-lineage Leukemia to CCAAT enhancer-binding proteins (C/EBPs)
Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers